文献速递主动脉疾病

标准化四开窗医师改良支架早期多中心注册研究

Early Outcomes from the Multicentre Standardised PHysician Modified Four Fenestration Endograft REgistry (S.PH.E.RE.).
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-06-03

S.PH.E.RE. 前瞻性多中心注册研究评估标准化四开窗医师改良支架(sPMEG)治疗超大及紧急复杂腹主动脉瘤的安全性和早期疗效。50例患者来自13个中心,中位随访8个月,技术成功率96%,30天死亡率为0%,主要不良事件率8%。尽管合并症负担高,早期结果良好,但需更长期随访。

要点

  • sPMEG治疗50例复杂腹主动脉瘤,技术成功率96%,30天死亡率0%。
  • 30天主要不良事件率8%,相关再干预率4%,无支架相关I型内漏、断裂。
  • 术后几何完整性100%,垂直和水平靶血管-开窗错位分别仅1%和2%。

核心结论

  • 标准化四开窗医师改良支架治疗超大及紧急复杂腹主动脉瘤显示出良好的技术植入安全性、有效性和早期结果,尽管患者合并症率高。
  • 需要更长期随访以更好地确定该sPMEG方法的临床角色。

研究设计与样本

  • 前瞻性多中心注册研究(S.PH.E.RE.),纳入13个中心的50例复杂腹主动脉瘤。
  • 使用Valiant Captivia支架进行台上改良,开窗位置规划、技术和手术在多中心间标准化。
  • 主要终点为技术成功和早期死亡,次要终点为sPMEG不稳定性、主要不良事件和30天再干预。

主要发现

  • 平均年龄78±18岁,SVS合并症评分16±5,平均最大瘤径75±19 mm。
  • 动脉瘤类型:短颈9例(18%)、近肾18例(36%)、肾周15例(30%)、IV型胸腹8例(16%)。
  • 平均支架改良时间128±33分钟,平均总手术时间196±96分钟,无术中支架相关并发症。
  • 技术成功96%,2例靶肾血管插管失败;30天死亡率0%,主要不良事件率8%,相关再干预4%。

关键数值与推荐

  • 30天无支架相关I型内漏、连接断开或断裂。
  • 术后影像几何分析显示主支架100%完整性和194个加强开窗。
  • 垂直靶血管-开窗错位检出率1%,水平错位检出率2%。

临床怎么用

  • 该标准化sPMEG方法可用于治疗超大及紧急复杂腹主动脉瘤,早期技术成功率高且安全性良好。
  • 术后CT血管造影评估支架几何完整性和靶血管-开窗错位有助于早期监测。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of the study was to investigate the safety, efficacy, and early outcomes of a novel standardised approach to a four fenestration physician modified endograft (sPMEG) in the treatment of very large and urgent complex abdominal aortic aneurysms (cAAAs). METHODS: This was a prospective multicentre study (S.PH.E.RE., Standardised PHysician modified four fenestration Endograft REgistry). The Valiant Captivia endograft (Medtronic, Minneapolis, MN, USA) was used for on bench modifications. Planning of fenestration position, technique, and procedure were standardised across the participating centres. Primary endpoints were technical success and early death. Secondary endpoints were sPMEG instability, major adverse events, and re-intervention at 30 days. Graft geometric integrity and target vessel to fenestration misalignment (TV-FM) were evaluated on post-operative computed tomography angiograms. RESULTS: There were 50 cAAAs from 13 centres with a median follow up of 8 months. The mean age was 78 ± 18 years, with a Society for Vascular Surgery comorbidity score of 16 ± 5 and a mean maximum aneurysm diameter of 75 ± 19 mm. There were nine (18%) short neck, 18 (36%) juxtarenal, 15 (30%) pararenal abdominal aortic, and eight (16%) extent IV thoraco-abdominal aneurysms. Thirty-two patients (64%) were treated electively, while 13 (26%) had a symptomatic and five (10%) had a ruptured aneurysm. Mean graft modification time was 128 ± 33 minutes and mean total operating time was 196 ± 96 minutes. No intra-operative graft related complications were reported. Overall technical success was 96%, with failure to cannulate two target renal vessels. The 30 day mortality rate was 0%, and the major adverse event rate was 8%. Related re-intervention occurred in 4%. No graft related type I endoleak, disconnection, or fracture was reported at 30 days. All patients had successful early follow up imaging, and post-implantation geometric analysis showed 100% integrity of the main graft and 194 reinforced fenestrations. Vertical TV-FM was detected in 1%, and horizontal TV-FM in 2%. CONCLUSION: This real life registry using four fenestration sPMEGs for the treatment of very large and urgent cAAAs showed excellent technical implantation safety, efficacy, and early outcomes, despite the high patient comorbidity rates. Longer term follow up is needed to better define the clinical role of this sPMEG approach.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Piazza M, Spertino A, Colacchio EC, et al. Early Outcomes from the Multicentre Standardised PHysician Modified Four Fenestration Endograft REgistry (S.PH.E.RE.). Eur J Vasc Endovasc Surg. 2025. PMID: 40472964. doi:10.1016/j.ejvs.2025.05.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。